Christoph Mahlert
Inventor
Stats
- 1 US patents issued
- 34 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 34 US Applications Filed
- 72 Total Citation Count
- Aug 29, 2024 Most Recent Filing
- Jun 21, 2010 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
SEATTLE GENETICS, INC. | 5
1 1 1 | 2012
2014 2015 2016 |
BAYER INTELLECTUAL PROPERTY GMBH | 1
| 2012
|
BAYER PHARMA AKTIENGESELLSCHAFT | 1
1 | 2014
2015 |
Inventor Addresses
Address | Duration |
---|---|
DE | Apr 18, 13 - Apr 18, 13 |
Koln, DE | Sep 20, 12 - Sep 20, 12 |
München, DE | Aug 18, 22 - Aug 18, 22 |
Wuppertal, DE | Mar 14, 13 - Mar 27, 25 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 32 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 12 |
C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0099,600 | 2025 | Active Metabolites of Kinesin Spindle Protein Inhibitor Conjugates | 0 |
12144865 | 2024 | Antibody drug conjugates with enzymatically cleavable groups | 0 |
12059472 | 2024 | Prodrugs of cytotoxic active agents having enzymatically cleavable groups | 0 |
2024/0043,379 | 2024 | PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS | 3 |
2023/0399,411 | 2023 | SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND ANTI-CD123-ANTIBODIES | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.